CannabisNewsBreaks

MondayApr 09, 2018 12:01 pm

CannabisNewsBreaks – Cannabis Wheaton Income Corp. (TSX.V: CBW) (OTC: CBWTF) Enters Agreement to Acquire Robinson’s Cannabis Inc.

Cannabis Wheaton Income Corp. (TSX.V: CBW) (OTC: CBWTF) this morning announced that it has entered into a share purchase agreement with Robinson's Cannabis Inc. to acquire all of the issued and outstanding shares of Robinson's. Robinson's is a privately-owned licensed producer applicant under the Access to Cannabis for Medical Purposes Regulations ("ACMPR") that has completed Health Canada’s paper-based review process and is currently in the confirmation of readiness stage. Per the terms of the share purchase agreement, the company will acquire all of the issued and outstanding shares of Robinson's. Upon the completion of the acquisitions, which is subject to…

Continue Reading

FridayApr 06, 2018 3:23 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH Technology Could Revolutionize Smokeless Tobacco

Lexaria Bioscience’s (CSE: LXX) (OTCQB: LXRP) revolutionary DehydraTECH™ technology has proven to be effective in cannabinoid delivery and is now undergoing testing for nicotine. An article discussing the company reads: “Lexaria is now looking to out-license its DehydraTECH to third-party partners in the tobacco industry. These partnerships could pave the way for a healthier smoke-free option for the one billion smokers worldwide. Lexaria is the only company in the world that holds a patent for this oral technology, including the pill. A new U.S. patent award protects this nicotine delivery system, creating a path for what could be the world’s…

Continue Reading

FridayApr 06, 2018 3:09 pm

CannabisNewsBreaks – Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Employs Seasoned Executives to Shape Diverse Portfolio

Liberty Leaf Holdings (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P), along with its subsidiaries, has been strengthening its scientific, legal and accounting teams with experienced leadership additions. An article discussing the company reads: “Together, the team is building a diversified portfolio of companies. Through this portfolio, it is helping to market high quality, medicinal-grade cannabis products with great promise for both human and veterinary use as Canada nears openness to all aspects of marijuana use later this year. Liberty Leaf continues seeking out productive, revenue-generating cannabis ventures in which to invest while simultaneously building its own working capital base. Its North…

Continue Reading

FridayApr 06, 2018 12:57 pm

CannabisNewsBreaks – Xanthic Biopharma Inc. Receives Conditional Listing Approval from the CSE

Xanthic Biopharma, a premium cannabinoid life sciences and technology company, recently announced that it has been granted conditional listing approval from the Canadian Securities Exchange (“CSE”) to list its common shares under the ticker symbol xTHC. The listing is subject to the successful completion of customary listing requirements of the CSE. The company has requested April 19th as its first trading date. “We are thrilled to begin trading on the CSE especially on the eve of ‘4/20’. We are excited to have obtained the ticker symbol xTHC, which we feel is memorable and readily connected with “Xanthic”. Our team would…

Continue Reading

ThursdayApr 05, 2018 10:12 am

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Continues to Advance Sol-gel Drug Delivery Technology

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) believes that its unique cannabinoid-based, nose-to-brain delivery technology, which employs its Sol-gel platform, is on track to become the first of its kind to be FDA-approved. An article discussing the company’s technology reads: “PreveCeutical believes that its cannabinoid-based nose-to-brain delivery technology, using a Sol-gel platform, will be the first to gain Food and Drug Administration approval. Its water soluable, alcohol free nasal formulation which will be developed for use by adults, children and people of certain beliefs. … PreveCeutical’s groundbreaking Sol-gel delivery system displays significant benefits over other contemporary…

Continue Reading

WednesdayApr 04, 2018 9:26 am

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Posts Product Development Update

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning issued a corporate update regarding the progress of its bio-cannabis product pipeline. Per the update, a 1% CBD Oral Micelle Solution developed in Germany is set to market and the company has completed development of two topical creams that employ its patented formulation and delivery systems. Pivot anticipates that it will have numerous products available for sale in Canada on the date legalization officially begins. The company also expects to begin sales in California as of the third quarter 2018, including the launch of its proprietary…

Continue Reading

TuesdayApr 03, 2018 3:09 pm

CannabisNewsBreaks – Aurora Cannabis, Inc. (TSX: ACB) (OTCQX: ACBFF) and CanniMed Therapeutics Inc. (TSX: CMED) Name Interim CEO of CanniMed

Aurora Cannabis, Inc. (TSX: ACB) (OTCQX: ACBFF), together with CanniMed Therapeutics Inc. (TSX: CMED), recently announced that Brent Zettl has resigned from his position as CEO of CanniMed. Andrċ Jérôme was appointed as interim CEO and Zettl will remain available to CanniMed and Aurora in an advisory capacity to assist during the integration period. This update comes as Aurora nears the completion of the acquisition of all the outstanding shares of CanniMed. "The integration of Aurora and CanniMed is well underway, and we anticipate updating the market frequently on developments as CanniMed is aligned with the Aurora Standard and expands…

Continue Reading

MondayApr 02, 2018 2:13 pm

CannabisNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Aims to Become Canada’s Premier Cannabis Brand

British Columbia-based cannabis cultivation firm Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) is positioning itself to make the most of the Canadian cannabis industry’s anticipated spike. An article discussing the company reads: “Choom™ is targeting nothing less than becoming the premier recreational cannabis brand in Canada. With its fully-integrated business model, the company aims to be the seed-to-sale market leader in reaching the Canadian cannabis consumer. Choom™ intends to become a leading Canadian cannabis grower and will be developing a chain of high-end branded retail cannabis dispensaries in strategic Canadian jurisdictions. Choom™ retail stores will provide discriminating cannabis consumers a…

Continue Reading

ThursdayMar 29, 2018 3:43 pm

CannabisNewsBreaks – Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Strives to Attain GMP-compliant Procedures

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) continues to diversify its portfolio as the Canadian government prepares to legalize cannabis-infused edibles and beverages by mid-2019. An article discussing the company reads: “Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P), a vertically-integrated cannabis company with strategic investments in proven, revenue-generating businesses, is building a diversified portfolio that includes marketing a wide range of high quality, medicinal grade cannabis products with tremendous promise for both human and veterinary use. Liberty Leaf and its wholly owned subsidiary, North Road Ventures, recently signed an agreement with Cannabis Compliance Inc.…

Continue Reading

ThursdayMar 29, 2018 3:38 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Anticipates Additional Technology Licensing Contracts in 2018

Lexaria Bioscience’s (CSE: LXX) (OTCQB: LXRP) CEO Chris Bunka recently discussed the company’s plans regarding technology licensing contracts in an audio interview. An article further discussing the company reads: “LXRP is a British Columbia, Canada-based bioscience company that is a drug delivery platform innovator. The company has developed its patented DehydraTECH™ delivery technology platform, which it out-licenses to promote healthier ingestion methods and lower overall dosing. …Bunka said that LXRP believes that 6-12 more licensing contracts will be signed this year, both generating more revenue for the company and building greater shareholder value. “We’ve only just graduated from the demonstration…

Continue Reading